Literature DB >> 33908775

In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D β-lactamases.

Nichole K Stewart1, Marta Toth1, Anastasiya Stasyuk2, Sergei B Vakulenko1, Clyde A Smith2,3.   

Abstract

Class D β-lactamases have risen to notoriety due to their wide spread in bacterial pathogens, propensity to inactivate clinically important β-lactam antibiotics, and ability to withstand inhibition by the majority of classical β-lactamase inhibitors. Understanding the catalytic mechanism of these enzymes is thus vitally important for the development of novel antibiotics and inhibitors active against infections caused by antibiotic-resistant bacteria. Here we report an in crystallo time-resolved study of the interaction of the class D β-lactamase CDD-1 from Clostridioides difficile with the diazobicyclooctane inhibitor, avibactam. We show that the catalytic carboxylated lysine, a residue that is essential for both acylation and deacylation of β-lactams, is sequestered within an internal sealed pocket of the enzyme. Time-resolved snapshots generated in this study allowed us to observe decarboxylation of the lysine and movement of CO2 and water molecules through a transient channel formed between the lysine pocket and the substrate binding site facilitated by rotation of the side chain of a conserved leucine residue. These studies provide novel insights on avibactam binding to CDD-1 and into the catalytic mechanism of class D β-lactamases in general.

Entities:  

Keywords:  avibactam; catalytic mechanism; crystal structure; inhibition; β-lactamase

Mesh:

Substances:

Year:  2021        PMID: 33908775      PMCID: PMC8808381          DOI: 10.1021/acsinfecdis.1c00094

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.578


  49 in total

1.  The role of conserved surface hydrophobic residues in the carbapenemase activity of the class D β-lactamases.

Authors:  Marta Toth; Clyde A Smith; Nuno T Antunes; Nichole K Stewart; Lauren Maltz; Sergei B Vakulenko
Journal:  Acta Crystallogr D Struct Biol       Date:  2017-07-28       Impact factor: 7.652

2.  In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.

Authors:  Sarah M McLeod; Samir H Moussa; Meredith A Hackel; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.

Authors:  Thomas F Durand-Réville; Satenig Guler; Janelle Comita-Prevoir; Brendan Chen; Neil Bifulco; Hoan Huynh; Sushmita Lahiri; Adam B Shapiro; Sarah M McLeod; Nicole M Carter; Samir H Moussa; Camilo Velez-Vega; Nelson B Olivier; Robert McLaughlin; Ning Gao; Jason Thresher; Tiffany Palmer; Beth Andrews; Robert A Giacobbe; Joseph V Newman; David E Ehmann; Boudewijn de Jonge; John O'Donnell; John P Mueller; Rubén A Tommasi; Alita A Miller
Journal:  Nat Microbiol       Date:  2017-06-30       Impact factor: 17.745

4.  Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases.

Authors:  D Golemi; L Maveyraud; S Vakulenko; J P Samama; S Mobashery
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

5.  Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus.

Authors:  J Andrew N Alexander; Mariia Radaeva; Dustin T King; Henry F Chambers; Artem Cherkasov; Som S Chatterjee; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

Review 6.  The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections.

Authors:  Krisztina M Papp-Wallace
Journal:  Expert Opin Pharmacother       Date:  2019-09-09       Impact factor: 3.889

7.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

8.  Enzyme intermediates captured "on the fly" by mix-and-inject serial crystallography.

Authors:  Jose L Olmos; Suraj Pandey; Jose M Martin-Garcia; George Calvey; Andrea Katz; Juraj Knoska; Christopher Kupitz; Mark S Hunter; Mengning Liang; Dominik Oberthuer; Oleksandr Yefanov; Max Wiedorn; Michael Heyman; Mark Holl; Kanupriya Pande; Anton Barty; Mitchell D Miller; Stephan Stern; Shatabdi Roy-Chowdhury; Jesse Coe; Nirupa Nagaratnam; James Zook; Jacob Verburgt; Tyler Norwood; Ishwor Poudyal; David Xu; Jason Koglin; Matthew H Seaberg; Yun Zhao; Saša Bajt; Thomas Grant; Valerio Mariani; Garrett Nelson; Ganesh Subramanian; Euiyoung Bae; Raimund Fromme; Russell Fung; Peter Schwander; Matthias Frank; Thomas A White; Uwe Weierstall; Nadia Zatsepin; John Spence; Petra Fromme; Henry N Chapman; Lois Pollack; Lee Tremblay; Abbas Ourmazd; George N Phillips; Marius Schmidt
Journal:  BMC Biol       Date:  2018-05-31       Impact factor: 7.431

9.  Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.

Authors:  Bin Liu; Robert E Lee Trout; Guo-Hua Chu; Daniel McGarry; Randy W Jackson; Jodie C Hamrick; Denis M Daigle; Susan M Cusick; Cecilia Pozzi; Filomena De Luca; Manuela Benvenuti; Stefano Mangani; Jean-Denis Docquier; William J Weiss; Daniel C Pevear; Luigi Xerri; Christopher J Burns
Journal:  J Med Chem       Date:  2019-12-16       Impact factor: 7.446

10.  Inhibition of the Clostridioides difficile Class D β-Lactamase CDD-1 by Avibactam.

Authors:  Nichole K Stewart; Marta Toth; Anastasiya Stasyuk; Mijoon Lee; Clyde A Smith; Sergei B Vakulenko
Journal:  ACS Infect Dis       Date:  2021-01-03       Impact factor: 5.084

View more
  3 in total

1.  C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation.

Authors:  Nichole K Stewart; Marta Toth; Maha A Alqurafi; Weirui Chai; Thu Q Nguyen; Pojun Quan; Mijoon Lee; John D Buynak; Clyde A Smith; Sergei B Vakulenko
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 2.  Not making the cut: Techniques to prevent RNA cleavage in structural studies of RNase-RNA complexes.

Authors:  Seth P Jones; Christian Goossen; Sean D Lewis; Annie M Delaney; Michael L Gleghorn
Journal:  J Struct Biol X       Date:  2022-03-11

3.  Analysis of a novel class A β-lactamase OKP-B-6 of Klebsiella quasipneumoniae: structural characterisation and interaction with commercially available drugs.

Authors:  Reinaldo Bellini; Isabella Alvim Guedes; Luciane Prioli Ciapina; Ana Tereza Ribeiro de Vasconcelos; Laurent Emmanuel Dardenne; Marisa Fabiana Nicolás
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-09-23       Impact factor: 2.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.